Suchergebnisse - "Bajel, Ashish"

PubPharm (6)

1

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens : a CIBMTR report

enthalten in: Blood advances | 2020

von Zhou, Z. | Nath, R. | Cerny, J. | +82

ErratumIn: Blood Adv. 2021 Jul 13;5(13):2752. - PMID 34242389

2

The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients

enthalten in: Annals of hematology | 2018

von Willcox, A. | Wong, E. | Nath, C. | +7

3

The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients

enthalten in: Annals of hematology | 2018

von Willcox, A. | Wong, E. | Nath, C. | +7

4

The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients

enthalten in: Annals of hematology | 2018

von Willcox, A. | Wong, E. | Nath, C. | +7

5

The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients

enthalten in: Annals of hematology | 2018

von Willcox, A. | Wong, E. | Nath, C. | +7

6

Impact of palifermin on mucosal toxicity in autologous stem cell transplants using busulfan-melphalan conditioning chemotherapy for Hodgkin and non-Hodgkin lymphoma

enthalten in: Leukemia & lymphoma | 2012

von Campbell, P. | Friebe, A. | Foulstone, P. | +3

1
[1]